GlaxoSmithKline to Pay $750 Million In Adulterated Drugs Case

BOSTON (Reuters) - GlaxoSmithKline Plc has agreed to pay $750 million and plead guilty to manufacturing and distributing adulterated drugs from a now closed plant in Puerto Rico, the U.S. Justice Department said on Tuesday.

Back to news